| Population | Patients with chronic or non‐healing wounds | 
|---|---|
| Intervention | Auto‐fluorescence imaging devices‐MolecuLight i:X device, fluorescence‐guided imaging | 
| Control | Conventional methods (e.g., wound swabs, biopsies, clinical signs). | 
| Outcomes | Diagnostic accuracy (sensitivity, specificity), microbiological yield, clinical utility in wound care decisions |